Drug Profile
Nimodipine oral solution - Arbor Pharmaceuticals
Alternative Names: AR 02; NymalizeLatest Information Update: 25 Nov 2021
Price :
$50
*
At a glance
- Originator Arbor Pharmaceuticals
- Class Antihaemorrhagics; Antihypertensives; Dihydropyridines; Esters; Small molecules
- Mechanism of Action Calcium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Subarachnoid haemorrhage
Most Recent Events
- 16 Dec 2013 Launched for Subarachnoid haemorrhage in USA (PO) before 16 December 2013 - First global launch
- 13 May 2013 Registered for Subarachnoid haemorrhage in USA (PO) - First global approval
- 02 Dec 2011 AR 02 receives Fast Track designation for Undefined in USA